"Designing Growth Strategies is in our DNA"
Critical care is the branch of medicine concerned with the diagnosis and management of life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in ICU or trauma centre. The rising prevalence of life-threatening conditions such as cardiovascular diseases, respiratory diseases, etc., increasing geriatric population, rising awareness and acknowledgement of vital organ’s test among patients, technological advancements are some of the key factors that are projected to drive the market growth during the forecast period. For instance, according to National Institute of Health (NIH), in 2016, about 8.5 % of people worldwide are aged 65 and over and this percentage is projected to jump over 17% of the world’s population by 2050.
Key Market Driver -
Rising prevalence of chronic disorders, increasing geriatric population
Key Market Restraint -
High costs associated critical care therapeutics
Rising prevalence of chronic disorders (cardiovascular disorders, respiratory disorders), growing geriatric population, increasing awareness among people about vital organ’s test, and government initiatives for increasing awareness regarding occurrences of chronic disorders are some of the factors that are driving the market growth. According to the American Heart Association's Heart and Stroke Statistics – 2019, nearly half of (48%, 121.5 million in 2016) of all adults in the United States have some type of cardiovascular disease.
However, high cost associated with critical care theraapeutics, and unfavourable reimbursement scenarios are some of the factors expected to hamper the growth of critical care therapeutics market.
By drug class, the market can be segmented into albumin, prothrombin complex concentrates, antithrombin concentrates, factor xiii concentrates, and fibrinogen concentrates. By application, the market can be segmented into deep vein thrombosis, pulmonary embolism (PE), acute coronary syndrome, atrial fibrillation, hemodialysis, coronary angioplasty, and surgeries
Geographically, the critical care therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global critical therapeutics market report includes Octapharma AG, Shire plc, Baxter, Bio Products Laboratory, Biotest AG, Kedrion S.p.A, Shanghai RAAS, and other prominent players.
The global critical care therapeutics market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global critical care therapeutics market due to an increasing prevalence of chronic disorders (cardiovascular diseases, respiratory diseases, etc.) in the U.S. According to the American Heart Association's Heart and Stroke Statistics – 2019, nearly half of (48%, 121.5 million in 2016) of all adults in the United States have some type of cardiovascular disease. Also, the availability of advanced healthcare facilities and research and development in critical care therapeutics are responsible factors for dominance.
To gain extensive insights into the market, Request for Customization
The market in Europe is likely to have substantial market growth throughout the forecast period owing to rising geriatric population, and rising prevalence of chronic disorders. Asia Pacific and Latin America are expected to register a fast market growth during the forecast period due to the increasing number of chronic disorders, awareness about the vital organ’s test among the people and increased government initiatives for increasing awareness regarding occurrences of chronic disorders. On the other hand, Middle East and Africa is projected to surge the critical care therapeutics market in the near future.
By Drug Class
Critical Care Therapeutics Industry Developments
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry